Redona Therapeutics
Watertown
About Redona Therapeutics
Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $66.8M
- Last round: Series Unknown (Jul 2023)
- Website: redonatx.com
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/redona-therapeutics-75434 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.